PPM1D and neoplasm: For the HER18R tumor bearing wild type p53, dual inhibition of WIP1 and miR-21 exhibited the best anti-tumor capacity with over 95% of tumor growth inhibition when compared with the tumor from the control group (Fig. 8c–e).